Association of genetically enhanced lipoprotein lipase–mediated lipolysis and low-density lipoprotein cholesterol–lowering alleles with risk of coronary disease and type 2 diabetes
<strong>Importance</strong> Pharmacological enhancers of lipoprotein lipase (LPL) are in preclinical or early clinical development for cardiovascular prevention. Studying whether these agents will reduce cardiovascular events or diabetes risk when added to existing lipid-lowering drugs...
Asıl Yazarlar: | Lotta, LA, Stewart, ID, Sharp, SJ, Day, FR, Burgess, S, Luan, J, Bowker, N, Cai, L, Li, C, Wittemans, LBL, Kerrison, ND, Khaw, K-T, McCarthy, MI, O'Rahilly, S, Scott, RA, Savage, DB, Perry, JRB, Langenberg, C, Wareham, NJ |
---|---|
Materyal Türü: | Journal article |
Baskı/Yayın Bilgisi: |
American Medical Association
2018
|
Benzer Materyaller
-
Association of genetically enhanced lipoprotein lipase-mediated lipolysis and low-density lipoprotein cholesterol-lowering alleles with risk of coronary disease and type 2 diabetes
Yazar:: Lotta, L, ve diğerleri
Baskı/Yayın Bilgisi: (2018) -
Endothelial lipase mediates efficient lipolysis of triglyceride-rich lipoproteins.
Yazar:: Sumeet A Khetarpal, ve diğerleri
Baskı/Yayın Bilgisi: (2021-09-01) -
Mathematical Modelling of Material Transfer to High-Density Lipoprotein (HDL) upon Triglyceride Lipolysis by Lipoprotein Lipase: Relevance to Cardioprotective Role of HDL
Yazar:: Svetlana Schekatolina, ve diğerleri
Baskı/Yayın Bilgisi: (2022-07-01) -
Human triacylglycerol-rich lipoprotein subfractions as substrates for lipoprotein lipase.
Yazar:: Fisher, R, ve diğerleri
Baskı/Yayın Bilgisi: (1995) -
Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein.
Yazar:: Karpe, F, ve diğerleri
Baskı/Yayın Bilgisi: (1993)